DYMISTA - 0037-0245-23 - (Azelastine Hydrochloride and Fluticasone Propionate)

Alphabetical Index


Drug Information of DYMISTA

Product NDC: 0037-0245
Proprietary Name: DYMISTA
Non Proprietary Name: Azelastine Hydrochloride and Fluticasone Propionate
Active Ingredient(s): 137; 50    ug/1; ug/1 & nbsp;   Azelastine Hydrochloride and Fluticasone Propionate
Administration Route(s): NASAL
Dosage Form(s): SPRAY, METERED
Coding System: National Drug Codes(NDC)

Labeler Information of DYMISTA

Product NDC: 0037-0245
Labeler Name: Meda Pharmaceuticals Inc.
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: NDA202236
Marketing Category: NDA
Start Marketing Date: 20120501

Package Information of DYMISTA

Package NDC: 0037-0245-23
Package Description: 1 BOTTLE, SPRAY in 1 BOX (0037-0245-23) > 120 SPRAY, METERED in 1 BOTTLE, SPRAY

NDC Information of DYMISTA

NDC Code 0037-0245-23
Proprietary Name DYMISTA
Package Description 1 BOTTLE, SPRAY in 1 BOX (0037-0245-23) > 120 SPRAY, METERED in 1 BOTTLE, SPRAY
Product NDC 0037-0245
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name Azelastine Hydrochloride and Fluticasone Propionate
Dosage Form Name SPRAY, METERED
Route Name NASAL
Start Marketing Date 20120501
Marketing Category Name NDA
Labeler Name Meda Pharmaceuticals Inc.
Substance Name AZELASTINE HYDROCHLORIDE; FLUTICASONE PROPIONATE
Strength Number 137; 50
Strength Unit ug/1; ug/1
Pharmaceutical Classes Histamine H1 Receptor Antagonists [MoA],Histamine-1 Receptor Inhibitor [EPC],Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA]

Complete Information of DYMISTA


General Information